Comparison of Compound Lidocaine Cream and Lidocaine–Prilocaine Cream for Pain Management in Facial Rejuvenation: A Randomized Controlled Trial
Journal of Cosmetic Dermatology · 2026-04 · 25 (4)
DOI: 10.1111/jocd.70865 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 19.04.2026. Verfasst von Li Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Plastic Surgery Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Hauptthemen laut MEDLINE: Anesthetics, Local, Rejuvenation, Lidocaine, Lidocaine, Prilocaine Drug Combination. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schmerzmanagement
Abstract (Originalsprache)
Background
Effective pain management is essential for enhancing patient satisfaction and treatment compliance during facial rejuvenation procedures. Compound lidocaine cream and lidocaine–prilocaine cream are commonly used topical anesthetics in clinical practice; however, high‐quality randomized controlled trials directly comparing their analgesic efficacy and safety in facial rejuvenation remain limited.
Objective
This study aimed to compare the analgesic efficacy and safety of compound lidocaine cream and lidocaine–prilocaine cream in patients undergoing facial rejuvenation procedures.
Methods
This single‐center, prospective, randomized controlled trial enrolled 100 patients undergoing facial rejuvenation between January 2024 and June 2025. Participants were randomly assigned to receive either compound lidocaine cream ( n = 47) or lidocaine–prilocaine cream ( n = 53). The primary outcome was procedural pain intensity, assessed using a 10‐point visual analog scale (VAS). Secondary outcomes included the incidence of adverse reactions, patient satisfaction, and treatment compliance.
Results
Baseline characteristics were comparable between the two groups ( p > 0.05). The mean pain score was significantly lower in the compound lidocaine cream group than in the lidocaine–prilocaine cream group (2.51 ± 1.80 vs. 3.75 ± 1.74; t = −3.48, p < 0.001). Adverse reactions occurred in 4.3% (2/47) of patients in the compound lidocaine cream group and 11.3% (6/53) in the lidocaine–prilocaine cream group, with no statistically significant difference between groups (χ 2 = 1.89, p = 0.169).
Conclusion
Compound lidocaine cream demonstrated superior analgesic efficacy in this clinical comparison; however, differences in anesthetic concentration, application technique, and lack of participant blinding should be considered when interpreting these findings. Larger studies with standardized dosing and blinding are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Plastic Surgery Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
ORCID-Profile: Chen Yuan
Zitieren
APA
Liu, L., Zhang, F., Han, C., Yuan, C., Han, M., Zhang, C., & Li, L. (2026). Comparison of Compound Lidocaine Cream and Lidocaine–Prilocaine Cream for Pain Management in Facial Rejuvenation: A Randomized Controlled Trial. Journal of Cosmetic Dermatology, 25(4). https://doi.org/10.1111/jocd.70865
Vancouver
Liu L, Zhang F, Han C, Yuan C, Han M, Zhang C, et al. Comparison of Compound Lidocaine Cream and Lidocaine–Prilocaine Cream for Pain Management in Facial Rejuvenation: A Randomized Controlled Trial. Journal of Cosmetic Dermatology. 2026;25(4). doi:10.1111/jocd.70865
BibTeX
@article{Liu2026,
author = {Liu, Li and Zhang, Fei and Han, Cuifang and Yuan, Chen and Han, Mengqi and Zhang, Changyu and Li, Li},
title = {Comparison of Compound Lidocaine Cream and Lidocaine–Prilocaine Cream for Pain Management in Facial Rejuvenation: A Randomized Controlled Trial},
journal = {Journal of Cosmetic Dermatology},
year = {2026},
volume = {25},
number = {4},
doi = {10.1111/jocd.70865}
}
EUVIMED